Jump to Content
ADGC

ADGC

Alzheimer's Disease
Genetics Consortium

  • Home
    • ADGC Core Projects
    • Contact
  • About
    • Program Overview
    • Members
    • Committees
    • Links
    • Alzheimer's Disease
    • Acknowledgements
  • Collaborative Data Access (SAGs)
    • SAG Proposal Instructions
    • SAG Overview
    • Current ADGC Special Analysis Group Projects (SAGs)
  • Publications
    • ADGC Publications
    • Publications Supported by the ADGC
    • Publications Using ADGC and IGAP Summary Statistics
  • For Members
    • Login

You are here

Home » ADGC Publications

ADGC Publications

Found 4 results
Filters: Author is Bellenguez, Celine and Keyword is Alzheimer Disease  [Clear All Filters]
2022
Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, van Rooij JGJ, Sims R, Ahmad S, Amin N et al..  2022.  Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease.. Nat Genet. 54(12):1786-1794.
2020
Sherva R, Gross A, Mukherjee S, Koesterer R, Amouyel P, Bellenguez C, Dufouil C, Bennett DA, Chibnik L, Cruchaga C et al..  2020.  Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.. Alzheimers Dement. 16(8):1134-1145.
2017
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
2014
Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E et al..  2014.  SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.. Hum Mol Genet. 23(24):6644-58.
If you need assistance please email info@adgenetics.org
© 2009-2025 University of Pennsylvania School of Medicine